Case number 1:18-cv-00987
Teijin Limited et al v. Torrent Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 20, 2018 | 13 | Patent/Trademark Report to Commissioner (1) |
| Nov 20, 2018 | 12 | SO ORDERED (3) Docket Text: SO ORDERED, re [11] Stipulation of Dismissal filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals U.S.A., Inc., ***Civil Case Terminated. Signed by Judge Colm F. Connolly on 11/19/2018. (fms) |
| Nov 20, 2018 | 13 | Signed Stipulation of Dismissal (3) |
| Nov 20, 2018 | 13 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,361,676 B2 ;8,372,872 B2 ;9,107,912 B2. (Attachments: # (1) Signed Stipulation of Dismissal)(fms) |
| Nov 19, 2018 | 11 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal by Takeda Pharmaceuticals U.S.A., Inc., Teijin Limited, Teijin Pharma Limited. (Blumenfeld, Jack) |
| Oct 1, 2018 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals U.S.A., Inc.: For Torrent Pharma Inc. waiver sent on 9/27/2018, answer due 11/26/2018. (Blumenfeld, Jack) |
| Oct 1, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals U.S.A., Inc.: For Torrent Pharmaceuticals Ltd. waiver sent on 9/27/2018, answer due 11/26/2018. (Blumenfeld, Jack) |
| Sep 12, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER by Judge Colm F. Connolly on 9/12/2018: In light of the reassignment of this case, the Court HEREBY ORDERS that the prior referral to Magistrate Judge Sherry R. Fallon is withdrawn. Associated Cases: 1:18-cv-00881-CFC-SRF, 1:18-cv-00987-CFC-SRF(nmf) |
| Aug 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-00881-CFC-SRF, 1:18-cv-00987-CFC-SRF (rjb) |
| Aug 31, 2018 | 8 | Letter (1) Docket Text: Letter to The Honorable Sherry R. Fallon from Jack B. Blumenfeld regarding coordinated discovery and Markman - re (7 in 1:18-cv-00881-CFC-SRF, 7 in 1:18-cv-00987-CFC-SRF) Order. (Blumenfeld, Jack) |
| Jul 31, 2018 | 7 | Order (2) Docket Text: ORDER regarding markman and discovery proceedings. Signed by Judge Sherry R. Fallon on 7/31/2018. Associated Cases: 1:18-cv-00881-VAC-SRF, 1:18-cv-00987-VAC-SRF(lih) |
| Jul 5, 2018 | N/A | Case Assigned/Reassigned (0) |
| Jul 5, 2018 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) (rjb) |
| Jul 5, 2018 | N/A | Remark (0) Docket Text: **NOTE: If the parties jointly consent to Magistrate Judge Fallons jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and Trial will be presided over by Judge Fallon consistent with 28 U.S.C. ยง 636. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued May 26, 2017 and available on the District Court's website), upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be reassigned to a visiting District Judge, and any further dates in the Scheduling Order, including the Pretrial Conference and Trial dates, may be adjusted dependent on the availability of the visiting District Judge.** (lih) |
| Jul 2, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Torrent Pharma Inc. on 7/2/2018; Torrent Pharmaceuticals Ltd. on 7/2/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Jul 2, 2018 | 1 | Complaint (15) |
| Jul 2, 2018 | 1 | Exhibit A-H (153) |
| Jul 2, 2018 | 1 | Civil Cover Sheet (2) |
| Jul 2, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Jul 2, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/22/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/22/2020. (nmg) |
| Jul 2, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,361,676 B2 ;8,372,872 B2 ;9,107,912 B2. (nmg) |
| Jul 2, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teijin Limited for Teijin Pharma Limited filed by Teijin Limited, Teijin Pharma Limited. (nmg) |
| Jul 2, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International, AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (nmg) |
| Jul 2, 2018 | 1 | Main Document (15) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2412258.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit A-H, # (2) Civil Cover Sheet)(nmg) |
